Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Scott

Showing results (221-230 of 222) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 222 results.
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Discovery of new piperidine amide triazolobenzodiazepinones as intestinal-selective CCK1 receptor agonistsKimberly O Cameron, Elena E Beretta, Yue Chen, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesityRichard L Elliott, Kimberly O Cameron, Janice E Chin, et al.
Pageof 23

Showing results (221-230 of 222) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 222 results.
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Discovery of new piperidine amide triazolobenzodiazepinones as intestinal-selective CCK1 receptor agonistsKimberly O Cameron, Elena E Beretta, Yue Chen, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesityRichard L Elliott, Kimberly O Cameron, Janice E Chin, et al.
Pageof 23